News
Chief Executive Albert Bourla says he is hopeful about finding a solution in response to Trump’s demand for price cuts.
Pfizer ( PFE) CEO Albert Bourla said Tuesday he has a "special relationship" with President Trump, cemented during the ...
Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...
Second-quarter adjusted earnings came in at 78 cents a share on revenue of $14.7 billion, beating expectations.
13hon MSN
‘We will work collaboratively’: Big Pharma admits it is discussing Trump’s plan to lower drug prices
Pfizer CEO says drugmakers ‘are all ready to roll up their sleeves and execute’ as president demands more direct-to-consumer ...
Pfizer Inc.’s stock was rallying Tuesday after the drug giant lifted its 2025 adjusted profit estimate, on the heels of a 10% ...
CEO says pharma executives discussed Trump's call to launch DTC initiatives under his Most Favored Nation policy to lower U.S ...
Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...
The controversial move affects development of vaccines against COVID-19, flu and H5N1, drawing criticism from public health ...
10h
Axios on MSNTrump admin pulls funding for new mRNA vaccines
Health Secretary Robert F. Kennedy Jr. said Tuesday that the government is pulling $500 million in funding to develop new ...
Chief Executive Albert Bourla told analysts he is hopeful about finding a solution in response to President Trump’s demands.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results